Vincerx Pharma, Inc.
VINC · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $28 | $139 | $118 | $965 |
| - Cash | $5 | $13 | $12 | $111 |
| + Debt | $0 | $3 | $3 | $4 |
| Enterprise Value | $23 | $128 | $110 | $858 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | -$1 | -$1 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | -$31 | -$39 | -$62 | -$39 |
| % Margin | – | – | – | – |
| Net Income | -$30 | -$40 | -$65 | -$39 |
| % Margin | – | – | – | – |
| EPS Diluted | -5.75 | -6.84 | -10.86 | -8.3 |
| % Growth | 15.9% | 37% | -30.8% | – |
| Operating Cash Flow | -$26 | -$40 | -$60 | -$33 |
| Capital Expenditures | $0 | $0 | $0 | -$5 |
| Free Cash Flow | -$26 | -$40 | -$60 | -$39 |